233 related articles for article (PubMed ID: 14617686)
1. Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.
de Medina P; Payré BL; Bernad J; Bosser I; Pipy B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Pharmacol Exp Ther; 2004 Mar; 308(3):1165-73. PubMed ID: 14617686
[TBL] [Abstract][Full Text] [Related]
2. The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors.
de Medina P; Boubekeur N; Balaguer P; Favre G; Silvente-Poirot S; Poirot M
J Pharmacol Exp Ther; 2006 Oct; 319(1):139-49. PubMed ID: 16835370
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.
Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M
J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329
[TBL] [Abstract][Full Text] [Related]
4. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.
Watanabe T; Nishio K; Kanome T; Matsuyama TA; Koba S; Sakai T; Sato K; Hongo S; Nose K; Ota H; Kobayashi Y; Katagiri T; Shichiri M; Miyazaki A
Circulation; 2008 Feb; 117(5):638-48. PubMed ID: 18212280
[TBL] [Abstract][Full Text] [Related]
5. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
[TBL] [Abstract][Full Text] [Related]
6. Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages.
Murakami S; Yamagishi I; Asami Y; Sato M; Tomisawa K
Cell Mol Biol (Noisy-le-grand); 1996 Sep; 42(6):865-72. PubMed ID: 8891354
[TBL] [Abstract][Full Text] [Related]
7. Regulation of sterol carrier protein 2 (SCP2) gene expression in rat peritoneal macrophages during foam cell formation. A key role for free cholesterol content.
Hirai A; Kino T; Tokinaga K; Tahara K; Tamura Y; Yoshida S
J Clin Invest; 1994 Dec; 94(6):2215-23. PubMed ID: 7989577
[TBL] [Abstract][Full Text] [Related]
8. Esculeogenin A, a new tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in ApoE-deficient mice by inhibiting ACAT.
Fujiwara Y; Kiyota N; Hori M; Matsushita S; Iijima Y; Aoki K; Shibata D; Takeya M; Ikeda T; Nohara T; Nagai R
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2400-6. PubMed ID: 17872457
[TBL] [Abstract][Full Text] [Related]
9. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal macrophages from stroke-prone spontaneously hypertensive rats accumulate more cholesteryl ester than do macrophages from Wistar-Kyoto rats.
Murakami S; Nara Y; Yamori Y
Biochem Biophys Res Commun; 1995 Jun; 211(2):547-53. PubMed ID: 7794268
[TBL] [Abstract][Full Text] [Related]
11. The role of cholesterol esterification in ovarian steroidogenesis: studies in cultured swine granulosa cells using a novel inhibitor of acyl coenzyme A: cholesterol acyltransferase.
Veldhuis JD; Strauss JF; Silavin SL; Kolp LA
Endocrinology; 1985 Jan; 116(1):25-30. PubMed ID: 3917248
[TBL] [Abstract][Full Text] [Related]
12. Effects of an anti-oxidative ACAT inhibitor on apoptosis/necrosis and cholesterol accumulation under oxidative stress in THP-1 cell-derived foam cells.
Miike T; Shirahase H; Jino H; Kunishiro K; Kanda M; Kurahashi K
Life Sci; 2008 Jan; 82(1-2):79-84. PubMed ID: 18037448
[TBL] [Abstract][Full Text] [Related]
13. Manzamine A, a marine-derived alkaloid, inhibits accumulation of cholesterol ester in macrophages and suppresses hyperlipidemia and atherosclerosis in vivo.
Eguchi K; Fujiwara Y; Hayashida A; Horlad H; Kato H; Rotinsulu H; Losung F; Mangindaan RE; de Voogd NJ; Takeya M; Tsukamoto S
Bioorg Med Chem; 2013 Jul; 21(13):3831-8. PubMed ID: 23665143
[TBL] [Abstract][Full Text] [Related]
14. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.
Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG
Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354
[TBL] [Abstract][Full Text] [Related]
15. Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase enzyme.
Ohgami N; Kuniyasu A; Furukawa K; Miyazaki A; Hakamata H; Horiuchi S; Nakayama H
Biochem Biophys Res Commun; 2000 Oct; 277(2):417-22. PubMed ID: 11032738
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone.
Yang L; Yang JB; Chen J; Yu GY; Zhou P; Lei L; Wang ZZ; Cy Chang C; Yang XY; Chang TY; Li BL
Cell Res; 2004 Aug; 14(4):315-23. PubMed ID: 15353128
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: evaluation of E5324, an acyl-CoA cholesterol acyltransferase inhibitor.
Nicholson AC; Pomerantz KB; Fujimori T; Hajjar DP
Lipids; 1995 Aug; 30(8):771-4. PubMed ID: 7475994
[TBL] [Abstract][Full Text] [Related]
18. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
[TBL] [Abstract][Full Text] [Related]
19. [Effect of the monooxygenase activity inhibitor ketoconazole on cholesterol esterification in mouse peritoneal macrophages].
Dushkin MI; Mandrikova EV; Liubimov GIu; Vol'skiĭ NN; Dolgov AV
Biokhimiia; 1990 Sep; 55(9):1607-15. PubMed ID: 2078637
[TBL] [Abstract][Full Text] [Related]
20. Auraptene is an inhibitor of cholesterol esterification and a modulator of estrogen receptors.
de Medina P; Genovese S; Paillasse MR; Mazaheri M; Caze-Subra S; Bystricky K; Curini M; Silvente-Poirot S; Epifano F; Poirot M
Mol Pharmacol; 2010 Nov; 78(5):827-36. PubMed ID: 20702762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
